San Francisco Cancer Initiative’s Colorectal Cancer Task Force with the help of animator Mark Wooding of University of California, San Francisco created an educational video on colon cancer screening in English, Cantonese, and Spanish. These videos highlight the importance of colon cancer screening for individuals between the ages of 50 to 75. The two detection methods illustrated in the videos are the fecal immunochemical test (FIT) and Colonoscopy.
% of eligible San Francisco Women who have NOT had a mammogram in past 2 years
% of San Franciscans over 50 who have NOT undergone colorectal cancer screening
Breast Breast cancer: Mammograms make a difference, yet almost a third of eligible women in San Francisco have not had a mammogram in the last two years. This is considerably lower than the rest of California and more common in non-Caucasian communities.
Colorectal Colorectal cancer: When found early, colorectal cancer is highly treatable. However, at least 21% of San Franciscans over 50 do not undergo colorectal screening. In some systems and clinics, this rises to more than 60%.
Prostate Prostate cancer: Due to confusion about changing guidelines, many men over 40 are not offered PSA testing to detect prostate cancer early. Yet many experts believe PSA screening with appropriate follow-up and targeted treatment can play an important role in deaths from prostate cancer.
SF CAN partners will implement culturally-sensitive, community education and outreach to improve screening rates for some of the city’s most devastating cancers.
Liver Liver cancer: Hepatitis B, Hepatitis C, Human Papilloma Virus (HPV) and Human Immunodeficiency Virus (HIV) are major causes of liver, cervical, anal, and other cancers.
Liver cancer is the fifth most common cause of cancer deaths in San Francisco. It is more common among foreign-born Asians and their children, with rates increasing among Latinos and African Americans in San Francisco.
We can do more to prevent and treat these viruses through public education, early detection screening, vaccination for hepatitis B and HPV, monitoring, and use of proven antiviral drugs.